期刊文献+

乳腺癌患者血浆uPA、uPAR检测的临床意义 被引量:9

The clinical significance of the measuring the plasma level of uPA、uPAR for the patiants of breast carcinoma
下载PDF
导出
摘要 目的探讨血浆uPA、uPAR水平在乳腺癌侵袭和转移评定的临床意义。方法采用ELISA方法,测定经组织病理学确诊的女性乳腺癌初治患者50例和健康女性体检者20例的血浆uPA、uPAR水平。结果乳腺癌患者血浆uPA、uPAR水平明显升高,与对照组比较差异有统计学意义(P<0.001);血浆uPA、uPAR水平随原发肿瘤的增大、腋淋巴结的转移以及分期而增高(P<0.05)。结论乳腺癌患者血浆uPA和uPAR的水平增高,与分期、腋淋巴结转移及原发肿瘤的大小密切相关,是乳腺癌侵袭和转移判定的有意义的指标。 Objective To study the clinical significance of the plasma levels of uPA,uPAR for the invasion and metastasis of the breast carcinoma. Methods Using ELISA method, measuring the plasma levels of uPA, uPAR of 50 female inpatients with breast carcinoma and 20 heathy cases, All patients visited a doctor for the first time. Results The plasma levels of uPA, uPAR in the patients with breast carcinoma were significantly higher than the ones in the healthy(P 〈0. 001 ) ;the increased plasma levels of uPA,uPAR were correlated with the pathology stage, axillary lymph node metastases and primary tumor size. Conclusion The plasma levels of uPA, uPAR in the patients with breast carcinoma were significantly high, and the increased plasma levels of uPA, uPAR were correlated with the pathological stage, axillary lymph node metastases and primary tumor size ;that were the significance indexs for predicting the invasion and metastasis of the breast carcinoma.
出处 《宁夏医学杂志》 CAS 2008年第7期580-581,共2页 Ningxia Medical Journal
基金 宁夏自然科学基金资助项目编号NZ0664
关键词 乳腺癌 UPA UPAR 侵袭 转移 breast carcinoma uPA uPAR invasion metastasis
  • 相关文献

参考文献5

  • 1Pouya Pakneshan, Moshe Szyf, Shafaat A Rabbani. Methylation and inhibition of expression of uPA by the RAS oncogene : divergence of growth control and invasion in breast cancer cells [J]. Carcinogenesis,2005,26 (3) :557 - 564.
  • 2郭艳丽,闫慧明,杨林花,宋善俊.组织因子、尿激酶型纤溶酶原激活剂受体在乳腺癌中的表达[J].中国肿瘤,2005,14(2):130-132. 被引量:3
  • 3Maxime P Look,Wim L J van Putten,Michael J Duffy,et al. Pooled Analysis of Prognostic Impact of Urokinase - Type Plasminogen Activator and Its Inhibitor PAI- 1 in 8377 Breast Cancer Patients [J]. Journal of the National Cancer Institute,2002,94 (2) : 116 - 128.
  • 4Charles E de Bock,Zhen Lin,Takashi Itoh,et al. Inhibition of urokinase receptor gene expression and cell invasion by anti -uPAR DNAzymes in osteosarcoma cells[J]. FEBS J,2005,272:3572-3582.
  • 5Pierga JY, Bonneton C, Magdelenat H, et al. Real - time quantitative PCR determination of urokinase - type plasminogen activator receptor (uPAR) expression of isolated micrometastatic cells from bone marrow of breast cancer patients [ J ]. Int J Cancer,2005,114 (2) :291 -298.

二级参考文献8

  • 1Cheng J,Bierhaus A,Schiekofer S,et al.Tissue factor-a receptor involved in the control of cellular properties,including angiogenesis [J].Thromb Haemost, 2001,86:334-345.
  • 2Donati MB,Lorenzet R.Coagulation factors and tumor cell biology:the role of tissue factor [J].Pathophysiol Haemost Thromb, 2003,33 (Suopl 1 ):22-25.
  • 3Sawada M,Miyake S, Ohdama S,et al. Expression of tissue factor in non-small cell lung cancer and its relationship to metastasis[J].Br J Cancer, 1999,79(3-4):472-477.
  • 4Lykke J, Nielsen HJ.The role of tissue factor in colorectal cancer[J].Eur J Surg Oncol,2003,29(5):417-422.
  • 5Mazar AP,Henkin J,Goldfarb RH.The urokinase plasminogen activator system in cancer:implications for tumor angiogenesis and metastasis [J].Angiogenesis,1999,3(1):15-32.
  • 6Taniguchi T, KakkarAK,Tuddenham EGD,et al. Enhanced expression of urokinase receptor induced through the tissue factor-factor Ⅶ a pathway in human pancreatic cancer[J].Cancer Res, 1998,58(19) :4461-4467.
  • 7方峻,宋善俊.活化的血液凝固因子Ⅶa和组织因子复合物介导信号传导与肿瘤生长、浸润及转移[J].中华血液学杂志,2002,23(5):279-280. 被引量:15
  • 8杨桂斌,沈孟贤.纤溶酶原激活系统与肿瘤转移[J].国外医学(临床生物化学与检验学分册),2002,23(3):141-141. 被引量:3

共引文献2

同被引文献67

引证文献9

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部